Skip to content
← Catalog

Umoja Biopharma · VivoVec platform · UB-VV100 / UB-VV400 (independent · not acquired)

Umoja Biopharma · 美国 in vivo CAR-T 公司 · VivoVec 第三代 lentiviral immune-shielded vector 平台 · 主要 pipeline UB-VV100 (T cell engager) / UB-VV400 (NK cell)。Independent therapeutic developer · 尚未被 big pharma 收购 · 是 in vivo CAR-T 空间内为数不多的 standalone reference。

Type
company
Domain
conference
Grade
conference
License
LIGHT_HOPE_proprietary
evidence_grade
B
category
in_vivo_car_t_lentiviral
status
draft
instance_tag
sunvax-antibody-2025
threat_level
complementary
competes_dimensions
in_vivo_cell_engineering
platform_tech
VivoVec · third-gen lentiviral immune-shielded vector
View at source ↗

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.